XML 75 R48.htm IDEA: XBRL DOCUMENT v3.20.4

RESEARCH AND DEVELOPMENT EXPENSES (Tables)

12 Months Ended

Dec. 31, 2020

RESEARCH AND DEVELOPMENT EXPENSES.

Schedule of research and development expenses

		Year Ended December 31,
		2020		2019		2018
		U.S. dollars in thousands
Payroll and related expenses		636		623		552
Professional services and consulting fees		1,752		2,345		2,297
Share-based payments		883		671		872
Clinical and pre-clinical trials		12,569		12,840		20,373
Intellectual property development		298		317		290
Other		353		623		478
		16,491		17,419		24,862

X

- Definition

The disclosure of research and development expense. [Refer: Research and development expense]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2020-01-01
-Paragraph 10
-Subparagraph e
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2020-01-01

+ Details

Name:	ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

n/a

+ References

No definition available.

+ Details

Name:	rdhl_IfrsResearchAndDevelopmentAbstract
Namespace Prefix:	rdhl_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration